Cargando…

Live cumulative network meta-analysis: protocol for second-line treatments in advanced non-small-cell lung cancer with wild-type or unknown status for epidermal growth factor receptor

INTRODUCTION: Many second-line treatments for advanced non-small-cell lung cancer (NSCLC) have been assessed in randomised controlled trials, but which treatments work the best remains unclear. Novel treatments are being rapidly developed. We need a comprehensive up-to-date evidence synthesis of all...

Descripción completa

Detalles Bibliográficos
Autores principales:	Créquit, Perrine, Trinquart, Ludovic, Ravaud, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985872/ https://www.ncbi.nlm.nih.gov/pubmed/27489157 http://dx.doi.org/10.1136/bmjopen-2016-011841

Ejemplares similares

Comparative efficacy and safety of second-line treatments for advanced non-small cell lung cancer with wild-type or unknown status for epidermal growth factor receptor: a systematic review and network meta-analysis
por: Créquit, Perrine, et al.
Publicado: (2017)

Wasted research when systematic reviews fail to provide a complete and up-to-date evidence synthesis: the example of lung cancer
por: Créquit, Perrine, et al.
Publicado: (2016)

Mapping of Crowdsourcing in Health: Systematic Review
por: Créquit, Perrine, et al.
Publicado: (2018)

Impact of Reporting Bias in Network Meta-Analysis of Antidepressant Placebo-Controlled Trials
por: Trinquart, Ludovic, et al.
Publicado: (2012)

Adjustment for reporting bias in network meta-analysis of antidepressant trials
por: Trinquart, Ludovic, et al.
Publicado: (2012)

Impact of single centre status on estimates of intervention effects in trials with continuous outcomes: meta-epidemiological study
por: Bafeta, Aïda, et al.
Publicado: (2012)

Influence of trial sample size on treatment effect estimates: meta-epidemiological study
por: Dechartres, Agnes, et al.
Publicado: (2013)

Reporting of results from network meta-analyses: methodological systematic review
por: Bafeta, Aïda, et al.
Publicado: (2014)

Comparison of Treatment Effect Estimates for Pharmacological Randomized Controlled Trials Enrolling Older Adults Only and Those including Adults: A Meta-Epidemiological Study
por: Seegers, Valérie, et al.
Publicado: (2013)

Analysis of the systematic reviews process in reports of network meta-analyses: methodological systematic review
por: Bafeta, Aïda, et al.
Publicado: (2013)

Complex systems approach to scientific publication and peer-review system: development of an agent-based model calibrated with empirical journal data
por: Kovanis, Michail, et al.
Publicado: (2015)

Differential Globalization of Industry- and Non-Industry–Sponsored Clinical Trials
por: Atal, Ignacio, et al.
Publicado: (2015)

Meta-Analysis of a Complex Network of Non-Pharmacological Interventions: The Example of Femoral Neck Fracture
por: Mosseri, Jonathan, et al.
Publicado: (2016)

The Global Burden of Journal Peer Review in the Biomedical Literature: Strong Imbalance in the Collective Enterprise
por: Kovanis, Michail, et al.
Publicado: (2016)

Evaluating alternative systems of peer review: a large-scale agent-based modelling approach to scientific publication
por: Kovanis, Michail, et al.
Publicado: (2017)

Efficacy and Safety of Docetaxel and Sodium Cantharidinate Combination vs. Either Agent Alone as Second-Line Treatment for Advanced/Metastatic NSCLC With Wild-Type or Unknown EGFR Status: An Open-Label, Randomized Controlled, Prospective, Multi-Center Phase III Trial (Cando-L1)
por: Wu, Lin, et al.
Publicado: (2021)

A test for reporting bias in trial networks: simulation and case studies
por: Trinquart, Ludovic, et al.
Publicado: (2014)

Avoidable waste of research related to outcome planning and reporting in clinical trials
por: Yordanov, Youri, et al.
Publicado: (2018)

Respective Contribution of Chronic Conditions to Disability in France: Results from the National Disability-Health Survey
por: Palazzo, Clémence, et al.
Publicado: (2012)

Almonertinib plus chemotherapy versus almonertinib alone in second-line treatment of advanced non-small cell lung cancer with mutated epidermal growth factor receptor: a retrospective study
por: Fang, Xiaoxu, et al.
Publicado: (2023)

Impact of interventions to improve the quality of peer review of biomedical journals: a systematic review and meta-analysis
por: Bruce, Rachel, et al.
Publicado: (2016)

The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status
por: Bronte, Giuseppe, et al.
Publicado: (2016)

Impact of evergreening on patients and health insurance: a meta analysis and reimbursement cost analysis of citalopram/escitalopram antidepressants
por: Alkhafaji, Ali A, et al.
Publicado: (2012)

Underrepresentation of Elderly People in Randomised Controlled Trials. The Example of Trials of 4 Widely Prescribed Drugs
por: Konrat, Cécile, et al.
Publicado: (2012)

A Case of Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer: Multi-Line Treatment and Resistance Mechanisms
por: Teixeira, Ana Raquel, et al.
Publicado: (2023)

Automatic classification of registered clinical trials towards the Global Burden of Diseases taxonomy of diseases and injuries
por: Atal, Ignacio, et al.
Publicado: (2016)

Effect of Primary Tumor Location on Second- or Later-Line Treatment With Anti-Epidermal Growth Factor Receptor Antibodies in Patients With Metastatic Colorectal Cancer: A Retrospective Multi-Center Study
por: Archwamety, Anita, et al.
Publicado: (2022)

Computed tomography-based radiomics quantification predicts epidermal growth factor receptor mutation status and efficacy of first-line targeted therapy in lung adenocarcinoma
por: Jiang, Meilin, et al.
Publicado: (2022)

Treatment Paradigms for Patients with Metastatic Non-Small Cell Lung Cancer, Squamous Lung Cancer: First, Second, and Third-Line
por: Al-Farsi, Abdulaziz, et al.
Publicado: (2014)

Three-Dimensional Convolutional Neural Network-Based Prediction of Epidermal Growth Factor Receptor Expression Status in Patients With Non-Small Cell Lung Cancer
por: Huang, Xuemei, et al.
Publicado: (2022)

Oligorecurrence Non–small Cell Lung Cancer After Failure of First-Line Chemotherapy: Computed Tomography–Guided (125)I Seed Implantation vs. Second-Line Chemotherapy
por: Wang, Hao, et al.
Publicado: (2020)

Factors associated with outcomes of second-line treatment for EGFR-mutant non-small-cell lung cancer patients after progression on first- or second-generation EGFR-tyrosine kinase inhibitor treatment
por: Chang, Cheng-Yu, et al.
Publicado: (2023)

A Review of the Correlation Between Epidermal Growth Factor Receptor Mutation Status and (18)F-FDG Metabolic Activity in Non-Small Cell Lung Cancer
por: Jiang, Maoqing, et al.
Publicado: (2022)

Retrospective practice review of treatment of metastatic non-small-cell lung cancer with second-line erlotinib
por: Melosky, B., et al.
Publicado: (2008)

First Line and Second Line Chemotherapy in Advanced Cholangiocarcinoma and Impact of Dose Reduction of Chemotherapy: A Retrospective Analysis
por: Möhring, Christian, et al.
Publicado: (2021)

Atezolizumab for the First-Line Treatment of Non-small Cell Lung Cancer (NSCLC): Current Status and Future Prospects
por: Ryu, Rachel, et al.
Publicado: (2018)

Epidermal growth factor receptor mutations and brain metastases in non-small cell lung cancer
por: Zhao, Wei, et al.
Publicado: (2022)

The Influence of Anti-Infective Periodontal Treatment on C-Reactive Protein: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Demmer, Ryan T., et al.
Publicado: (2013)

Real World Evidence on Second-Line Palliative Chemotherapy in Advanced Pancreatic Cancer
por: Gränsmark, Emma, et al.
Publicado: (2020)

Survival of Patients with Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small Cell Lung Cancer Treated beyond the Second Line in the Tyrosine Kinase Inhibitor Era
por: Refeno, Valéry, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b0142v4nq5ldj70grj7610l833